MD Anderson’s Lauren Averett Byers receives TAMEST O’Donnell Award for seminal contributions to lung cancer research
Lauren Averett Byers, M.D., professor of Thoracic/Head & Neck Medical Oncology at The University of Texas MD Anderson Cancer Center, has received the 2025 Edith and Peter O’Donnell Award in Medicine from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST). The award recognizes her fundamental discoveries and contributions to identifying novel therapeutic strategies for small cell lung cancer (SCLC), which...
MD Anderson and AmMax Bio announce agreements to advance development of AMB-066 in colorectal cancer patients with minimal residual disease
The University of Texas MD Anderson Cancer Center and AmMax Bio, Inc. today announced a worldwide exclusive license agreement and clinical...
MD Anderson statement on BCBS TX ending Medicare Advantage and Medicaid plans
Blue Cross Blue Shield notified The University of Texas MD Anderson Cancer Center it will end its Letter of Agreement for Medicare Advantage...
Allison Institute scientific symposium features spatial biology breakthroughs, $5 million gift to support further efforts
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center hosted its second annual scientific symposium, “Immunotherapy in Space and Time: The Tumor Microenvironment,” on Oct. 10 at the TMC3 Collaborative Building in the Texas Medical Center’s Helix Park. The symposium, with more than 900 attendees, featured two Nobel laureates and a $5 million gift from the David and Eula Wintermann...
MD Anderson and Summit Therapeutics announce strategic collaboration to accelerate development of ivonescimab
The University of Texas MD Anderson Cancer Center and Summit Therapeutics, Inc. today announced a strategic five-year collaboration agreement...
MD Anderson and Rice launch Cancer Bioengineering Collaborative
The University of Texas MD Anderson Cancer Center and Rice University today announced the creation of the Cancer Bioengineering Collaborative...
MD Anderson Research Highlights: EHA 2024 Special Edition
ABSTRACTS: LB3439, LB3442, S131, S132, S136, S164, S222
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases...
MD Anderson and Sibylla Biotech announce strategic collaboration to discover and develop small-molecule protein degraders
The University of Texas MD Anderson Cancer Center and Sibylla Biotech today announced a strategic collaboration agreement to discover and...
Allison Institute announces appointment of two immunobiology experts as associate members
The James P. Allison Institute at The University of Texas MD Anderson Cancer Center today announced the appointment of its newest members,...
MD Anderson and Replay announce FDA clearance of IND application for first-in-class PRAME-targeted TCR NK cell therapy for hematological malignancies
The University of Texas MD Anderson Cancer Center and Replay today announced that the Food & Drug Administration (FDA) has issued...